Reaction

Melanocytic Naevus reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,328 reports · 127 co-occurring drugs

As of the last recalculation, Melanocytic Naevus appears in 4,328 FAERS reports alongside 127 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 56.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Vemurafenib	137	56.6	57.2
Encorafenib	71	35.0	35.3
Fingolimod Hcl	351	21.2	21.2
Siponimod	30	16.3	16.3
Cetuximab	55	8.5	8.6
Mometasone	32	8.4	8.5
Ketoconazole	30	8.4	8.4
Ketoconazole Foam	25	8.2	8.2
Ketoconazole Cream, 2%	25	8.1	8.2
Captopril	16	8.0	8.0
Dabrafenib	34	7.8	7.8
Alemtuzumab	31	7.8	7.8
Mupirocin Calcium	22	7.7	7.7
Clobetasol Propionate Ointment Usp, 0.05%	16	7.5	7.5
Clobetasol Propionate	16	7.5	7.5
Felodipine Extended-Release Tablets	17	7.2	7.2
Felodipine	17	7.2	7.2
Mupirocin	20	7.2	7.2
Infliximab-Dyyb	42	7.0	7.0
Finasteride	83	6.7	6.7
Minocycline	16	6.6	6.6
Alendronate Sodium	135	6.6	6.6
Meclizine Hcl 12.5Mg	18	6.4	6.4
Meclizine Hcl 25Mg	18	6.4	6.4
Meclizine Hcl 12.5 Mg	18	6.4	6.4
Meclizine Hcl 25 Mg	18	6.4	6.4
Risankizumab-Rzaa	104	6.2	6.2
Nitrofurantoin	21	6.1	6.2
Valsartan Oral	68	6.1	6.1
Nitrofurantoin (Monohydrate/Macrocrystals)	21	6.1	6.1
Mercaptopurine	21	5.8	5.9
Etonogestrel And Ethinyl Estradiol	26	5.7	5.7
Cephalexin	24	5.4	5.4
Tretinoin	9	5.3	5.3
Meclizine	18	5.3	5.3
Nebivolol	17	5.1	5.2
Dofetilide	11	5.0	5.0
Adalimumab	644	5.0	5.0
Meclizine Hydrochloride	20	4.9	4.9
Isotretinoin	50	4.9	4.9
Psyllium Husk	10	4.9	4.9
Clindamycin Phosphate	33	4.8	4.8
Triamcinolone Acetonide Ointment Usp, 0.05%	22	4.5	4.5
Trametinib	22	4.4	4.4
Terbinafine Hydrochloride	8	4.3	4.3
Clindamycin	25	4.3	4.3
Loperamide Hydrochloride Oral	9	4.2	4.2
Secukinumab	138	4.2	4.2
Drs. Clotrimazole	10	4.2	4.2
Family Wellness Clotrimazole	10	4.2	4.2
Clotrimazole Topical	10	4.2	4.2
Valsartan	88	4.1	4.1
Cladribine	8	4.0	4.0
Doxycycline	56	4.0	4.0
Erlotinib	8	4.0	4.0
Clotrimazole	10	3.9	3.9
Triamcinolone Acetonide	25	3.9	3.9
Doxycycline Hyclate	54	3.9	3.9
Erythromycin	15	3.9	3.9
Oxybutynin Chloride	7	3.8	3.8
Midazolam	20	3.8	3.8
Vismodegib	7	3.8	3.8
Loperamide Hydrochloride And Dimethicone	25	3.8	3.8
Midazolam Hydrochloride	21	3.8	3.8
Doxyclycline Hyclate	13	3.7	3.7
Fexofenadine Hcl	7	3.6	3.6
Biotin	23	3.6	3.6
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	22	3.5	3.5
Methocarbamol Tablets	12	3.5	3.5
Nebivolol Hydrochloride	24	3.4	3.4
Trazodone Hydrochloride	11	3.4	3.4
Progesterone	16	3.4	3.4
Loperamide Hcl	9	3.4	3.4
Niacin	8	3.3	3.3
Tizanidine	16	3.2	3.2
Infliximab	143	3.2	3.2
Teduglutide	9	3.2	3.2
Upadacitinib	54	3.2	3.2
Ibuprofen Sodium	28	3.2	3.2
Erlotinib Hydrochloride	8	3.1	3.1
Crisaborole	6	3.0	3.0
Fish Oil	56	3.0	3.0
Azelastine	11	3.0	3.0
Timolol Maleate	6	2.9	2.9
Sumatriptan Succinate	15	2.9	2.9
Acalabrutinib	7	2.8	2.8
Ibuprofen Tablets, Coated	24	2.7	2.7
Testosterone Cypionate	5	2.7	2.7
Sumatriptan	21	2.7	2.7
Conjugated Estrogens	32	2.7	2.7
Ruxolitinib	39	2.6	2.6
Estrogens, Conjugated	31	2.5	2.5
Conjugated Estrogens And Medroxyprogesterone Acetate	12	2.4	2.4
Loratadine And Pseudoephedrine Sulfate	4	2.4	2.4
Ibrutinib	39	2.3	2.3
Ustekinumab	48	2.3	2.3
Ocrelizumab	28	2.2	2.2
Bosutinib	4	2.1	2.1
Avapritinib	5	2.0	2.0
Golimumab	35	2.0	2.0
Somatropin	30	2.0	2.0
Niraparib	9	2.0	2.0
Natalizumab	73	1.9	1.9
Elexacaftor, Tezacaftor, And Ivacaftor	5	1.9	1.9
Panitumumab	6	1.8	1.8
Etanercept	211	1.7	1.7
Cortisone Acetate	4	1.6	1.6
Bimatoprost	9	1.5	1.5
Teriparatide	35	1.5	1.5
Teriflunomide	14	1.5	1.5
Peginterferon Beta-1A	4	1.5	1.5
Ipilimumab	13	1.4	1.4
Medroxyprogesterone Acetate	15	1.4	1.4
Cannabidiol	7	1.4	1.4
Ravulizumab	4	1.4	1.4
Relugolix	6	1.2	1.2
Dalfampridine	18	1.2	1.2
Durvalumab	5	1.2	1.2
Minoxidil Foam 5% (Womens)	8	1.2	1.2
Ixekizumab	8	1.0	1.0
Lenalidomide	87	1.0	1.0
Minoxidil	9	1.0	1.0
Aflibercept	6	0.9	0.9
Apremilast	28	0.9	0.9
Pirfenidone	7	0.8	0.8
Pimavanserin Tartrate	6	0.5	0.5
Adapalene	5	0.1	0.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.